The critical role of the <scp>ZNF217</scp> oncogene in promoting breast cancer metastasis to the bone
Aurélie Bellanger(Lyon 1 Université), Pascale A. Cohen(Lyon 1 Université), Balázs Győrffy(Semmelweis University), Maëva Ruel(Lyon 1 Université), Jean‐Luc Coll(Unknown), Véronique Maguer‐Satta(Université Claude Bernard Lyon 1), Evelyne Grisard(Lyon 1 Université), Ivan Bièche(Centre National de la Recherche Scientifique), Olivier Peyruchaud(Université Claude Bernard Lyon 1), Julien Vollaire(Inserm), Caterina F. Donini(Sapienza University of Rome), J. Lavaud(Inserm), Véronique Josserand(Centre National de la Recherche Scientifique), Isabelle Treilleux(Centre Léon Bérard), Julie A. Vendrell(Inserm), Irma Machuca‐Gayet(Université Claude Bernard Lyon 1)
Cited by 55
Related Papers
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
|PLoS ONE|2013|1.9k
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
|The Lancet Oncology|2014|410
SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas
|Nature Genetics|2015|375
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
|Annals of Oncology|2024|343
Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors
|Endocrine Reviews|2011|302